Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Wasatch Small Cap Growth Strategy 2024 Q1 Investor Letter | Buyside Digest

Back to Fund Profile (Wasatch Small Cap Growth Strategy)

Primary Source Intelligence • Q1 2024 Letter Analysis

Wasatch Small Cap Growth Strategy Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Wasatch Small Cap Growth Strategy. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+9.87%

Digest Analysis

Quick Take

"Wasatch Small Cap Growth underperformed in Q1 despite gains, as AI drove market returns. The team maintains their fundamentals-focused approach, avoiding macro speculation."

Executive Summary

Wasatch Small Cap Growth Strategy gained but underperformed the Russell 2000 Growth Index's 7.58% return in Q1 2024, with AI and technology driving much market performance. The team maintains their fundamental-focused approach, spending little time on macro factors and concentrating on company-specific revenue and earnings growth. Top contributors included Medpace Holdings, benefiting from biotech funding optimism, Nova Ltd from semiconductor demand, and HealthEquity from strong HSA business fundamentals. Key detractors were YETI facing competitive threats, Clearwater Analytics disappointing analyst expectations, and Five9 amid AI disruption concerns. Portfolio activity included adding Agilysys for diversification and exiting Neogen due to stalled synergies. Regarding AI, the managers avoid disrupted business models, favor companies using AI competitively, and selectively invest in AI-related firms while managing valuation risks. With projected double-digit growth rates for 2024 and reasonable small-cap valuations relative to large-caps, they remain optimistic about forward performance while maintaining their disciplined, fundamentals-driven investment approach.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The managers demonstrate moderate-high conviction through specific position sizing decisions (trimming Nova, adding to HealthEquity, maintaining small YETI position), clear thesis explanations for individual holdings, and decisive portfolio actions. However, the diversified approach and hedged language around AI opportunities prevent a higher score. The explanation of specific position management and clear fundamental analysis supports this conviction level.

Growth Outlook

50%

BearishBullish

Neutral (50%)

The managers express optimism about small-cap valuations and projected double-digit growth rates for 2024, describing reasonable valuations on both absolute and relative basis to large-caps. However, they also acknowledge risks around AI disruption and margin compression, balancing positive outlook with measured caution.

Risk Appetite

25%

DefensiveAggressive

Defensive (25%)

The portfolio shows selective risk management with trimming Nova on AI euphoria, maintaining small YETI position while evaluating, and adding diversification through new positions. This reflects a measured approach rather than aggressive risk-taking, with some defensive positioning around AI-related volatility.

Capital Deployment

15%

De-riskingDeploying

De-risking (15%)

Portfolio activity shows rotation rather than net deployment - adding Agilysys and buying more Clearwater while trimming Nova and exiting Neogen. The focus on increasing diversification and selective position adjustments suggests modest net activity without significant cash level changes, indicating limited net deployment.

Forward Guidance

40%

CautiousExpansionary

Neutral (40%)

The managers plan to continue their fundamentals-focused approach, selectively adding positions for diversification, and carefully evaluating AI opportunities. They express intent to maintain discipline while being open to opportunities, showing moderate deployment bias without aggressive expansion.

Language Signal

35%

BearishBullish

Bearish (35%)

Language includes positive terms like 'optimistic,' 'strong growth,' and 'attractive valuations' but is balanced with risk language around 'competitive threats,' 'disruption,' and 'asymmetric risks.' The tone is constructive but measured, with roughly balanced directional language.

Perceived Risk

55%

Low RiskElevated

Moderate Risk (55%)

The managers identify several specific risks including reduced margin for error in earnings estimates, AI disruption threats to certain companies, and historical precedent of bad investments during technological transformations. These risks are discussed with meaningful detail and specific examples, showing moderate risk awareness without alarm.

Opportunity Density

65%

ScarceAbundant

Abundant (65%)

The managers express optimism about the small-cap opportunity set, citing reasonable valuations on absolute and relative basis, projected double-digit growth rates across their companies, and ability to find new positions like Agilysys. This suggests a moderately rich opportunity environment with selective but available options.

Time Horizon

75%

Short-TermLong-Term

Decade+ (75%)

The managers explicitly state their investment horizon is measured in years, not quarters, and emphasize long-term earnings growth potential over multiple years. They reference holding through volatility and focus on multi-year growth projections, indicating a clear multi-year investment approach with patience for thesis realization.